212 related articles for article (PubMed ID: 30378279)
21. Prevalence and risk factors for depression and anxiety in Chinese patients with Parkinson disease.
Cui SS; Du JJ; Fu R; Lin YQ; Huang P; He YC; Gao C; Wang HL; Chen SD
BMC Geriatr; 2017 Nov; 17(1):270. PubMed ID: 29166864
[TBL] [Abstract][Full Text] [Related]
22. Considerations before initiating therapy in Parkinsonism: basing on the quality of life.
He SJ; Liu ZY; Yang YJ; Shen C; Du YJ; Zhou XY; Zhao J; Sun YM; Yang K; Wu JJ; Liu FT; Wang J
J Neurol; 2019 Dec; 266(12):3119-3125. PubMed ID: 31535268
[TBL] [Abstract][Full Text] [Related]
23. Non-motor symptoms in Chinese Parkinson's disease patients.
Gan J; Zhou M; Chen W; Liu Z
J Clin Neurosci; 2014 May; 21(5):751-4. PubMed ID: 24411328
[TBL] [Abstract][Full Text] [Related]
24. Non-motor symptoms and the quality of life in multiple system atrophy with different subtypes.
Zhang L; Cao B; Ou R; Wei QQ; Zhao B; Yang J; Wu Y; Shang H
Parkinsonism Relat Disord; 2017 Feb; 35():63-68. PubMed ID: 27993522
[TBL] [Abstract][Full Text] [Related]
25. A Comparison of Pain between Parkinson's Disease and Multiple System Atrophy: A Clinical Cross-Sectional Survey.
You HY; Wu L; Yang HT; Yang C; Ding XL
Pain Res Manag; 2019; 2019():3150306. PubMed ID: 30805069
[TBL] [Abstract][Full Text] [Related]
26. Factors impacting quality of life in multiple system atrophy.
Ali N; Nesspor V; Bang J; Scholz SW; Pantelyat A
Front Neurol; 2023; 14():1111605. PubMed ID: 36970533
[TBL] [Abstract][Full Text] [Related]
27. Altered structural connectivity of the motor subnetwork in multiple system atrophy with cerebellar features.
Shah A; Prasad S; Rastogi B; Dash S; Saini J; Pal PK; Ingalhalikar M
Eur Radiol; 2019 Jun; 29(6):2783-2791. PubMed ID: 30552481
[TBL] [Abstract][Full Text] [Related]
28. Depression and anxiety in multiple system atrophy.
Zhang LY; Cao B; Zou YT; Wei QQ; Ou RW; Zhao B; Wu Y; Shang HF
Acta Neurol Scand; 2018 Jan; 137(1):33-37. PubMed ID: 28748633
[TBL] [Abstract][Full Text] [Related]
29. Frequency and factors related to drooling in Chinese patients with multiple system atrophy: a cross-sectional study.
Chen Y; Huang H; Ning P; Zhao Q; Wang H; Shen Q; Xu Y
Clin Auton Res; 2019 Dec; 29(6):595-601. PubMed ID: 30864043
[TBL] [Abstract][Full Text] [Related]
30. Motor assessment of patients with multiple system atrophy: underuse of the Unified Multiple System Atrophy Rating Scale (UMSARS).
Ferreirós A; Castillo-Torres SA; Merello M
Clin Auton Res; 2023 Apr; 33(2):143-148. PubMed ID: 36971870
[TBL] [Abstract][Full Text] [Related]
31. Cognition in multiple system atrophy: neuropsychological profile and interaction with mood.
Balas M; Balash Y; Giladi N; Gurevich T
J Neural Transm (Vienna); 2010 Mar; 117(3):369-75. PubMed ID: 20091064
[TBL] [Abstract][Full Text] [Related]
32. Sleep disorders and their determinants in multiple system atrophy.
Ghorayeb I; Yekhlef F; Chrysostome V; Balestre E; Bioulac B; Tison F
J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):798-800. PubMed ID: 12023429
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Different Symptom Assessment Scales for Multiple System Atrophy.
Matsushima M; Yabe I; Oba K; Sakushima K; Mito Y; Takei A; Houzen H; Tsuzaka K; Yoshida K; Maruo Y; Sasaki H
Cerebellum; 2016 Apr; 15(2):190-200. PubMed ID: 26093615
[TBL] [Abstract][Full Text] [Related]
34. Excessive Daytime Sleepiness Is Associated With Non-motor Symptoms of Multiple System Atrophy: A Cross-Sectional Study in China.
Wang H; Tang X; Zhou J; Xu Y
Front Neurol; 2021; 12():798771. PubMed ID: 35087473
[No Abstract] [Full Text] [Related]
35. Prevalence of and factors associated with postural deformities in Chinese patients with multiple system atrophy.
Zhang L; Cao B; Zou Y; Wei QQ; Ou R; Zhao B; Yang J; Wu Y; Shang H
Parkinsonism Relat Disord; 2019 Jul; 64():324-327. PubMed ID: 30987897
[TBL] [Abstract][Full Text] [Related]
36. Potential outcome measures and trial design issues for multiple system atrophy.
May S; Gilman S; Sowell BB; Thomas RG; Stern MB; Colcher A; Tanner CM; Huang N; Novak P; Reich SG; Jankovic J; Ondo WG; Low PA; Sandroni P; Lipp A; Marshall FJ; Wooten F; Shults CW;
Mov Disord; 2007 Dec; 22(16):2371-7. PubMed ID: 17914727
[TBL] [Abstract][Full Text] [Related]
37. Clinical and polysomnographic features of patients with multiple system atrophy in Southwest China.
Guo XY; Cao B; Lei F; Huang L; Chen K; Song W; Zhao B; Tang X; Shang H
Sleep Breath; 2013 Dec; 17(4):1301-7. PubMed ID: 23563911
[TBL] [Abstract][Full Text] [Related]
38. Serum Cystatin C as a Potential Predictor of the Severity of Multiple System Atrophy With Predominant Cerebellar Ataxia: A Case-Control Study in Chinese Population.
Ye F; Wang T; Li H; Liang J; Wu X; Sheng W
Front Neurosci; 2021; 15():663980. PubMed ID: 34566557
[No Abstract] [Full Text] [Related]
39. Impact of depressive symptoms on self-perceived severity of autonomic dysfunction in multiple system atrophy: relevance for patient-reported outcomes in clinical trials.
Martinez J; Palma JA; Norcliffe-Kaufmann L; Garakani A; Kaufmann H
Clin Auton Res; 2020 Jun; 30(3):215-221. PubMed ID: 32246226
[TBL] [Abstract][Full Text] [Related]
40. Comparison of tandospirone and escitalopram as a symptomatic treatment in Multiple System Atrophy-cerebellar ataxia: An open-label, non-controlled, 4 weeks observational study.
Quan M; Gao J; Xu S; Guo D; Jia J; Wang W
J Psychiatr Res; 2023 Dec; 168():133-139. PubMed ID: 37907036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
